Skip to content
★ Sign in to follow
SR

Susan Rolih

Executive
Meridian Bioscience Inc
Total declarations
46
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€312k

Latest filing published 19 Nov 2018 for Meridian Bioscience INC.

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

Susan Rolih: trading record in brief

Susan Rolih discloses dealings in Meridian Bioscience Inc to SEC (Form 4). Over a trading history stretching from 12 November 2008 to 16 November 2018, the count stands at 46 filings.

Every open-market trade on record is a sale: 2 sales worth €312k. Besides market trades, the filings include 28 share grants and 7 option exercises.

The newest entry dates from 19 November 2018: a share grant, in Meridian Bioscience Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Susan Rolih

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations45 total

25 of 45 declarations